Results 151 to 160 of about 49,792,250 (291)

Cefepime exposure in prolonged or intermittent infusion in critically ill children

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Cefepime is commonly used in critically ill children for whom there is a high between‐subject variability. To reach the therapeutic pharmacokinetic (PK) target in critically ill patients, prolonged infusion of beta‐lactams seems to be the most efficient.
Marc Hobeika   +12 more
wiley   +1 more source

Allelopathic interactions between Potamogelon maackianus and Microcystis aeruginosa

open access: yes, 2007
The allelopathic interactions between Potamogeton maackianus and toxic cyanobacteria (Microcystis aeruginosa) were studied. P maackianus inhibited the growth of M.
Cheng, S. P.   +5 more
core  

Antibiogram profile of MDR P. aeruginosa.

open access: yes, 2016
Antibiogram profile of MDR P. aeruginosa.
Debarati Choudhury (687979)   +8 more
core   +1 more source

Rifampicin and long‐acting cabotegravir‐rilpivirine: Therapeutic drug monitoring‐guided management of a major drug–drug interaction—A case report

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Long‐acting injectable cabotegravir/rilpivirine (LAI CAB/RPV) is subject to clinically significant drug–drug interactions with strong enzyme inducers such as rifampicin due to markedly reduced drug exposure and potential development of resistance. However, real‐world evidence on managing this interaction remains scarce.
Lorenzo Ciullini   +3 more
wiley   +1 more source

Bacteriophage and phenotypic variation in Pseudomonas aeruginosa biofilm development

open access: yes, 2004
A current question in biofilm research is whether biofilm-specific genetic processes can lead to differentiation in physiology and function among biofilm cells. In Pseudomonas aeruginosa, phenotypic variants which exhibit a small-colony phenotype on agar
Webb, Jeremy S.   +6 more
core   +1 more source

Structural compatibility between β‐lactams and substrate binding pockets of IMP‐1 and NDM‐1 determines the substrate spectrum

open access: yesBulletin of the Korean Chemical Society, EarlyView.
Chemical structures of three β‐lactam classes and the substrate‐binding pockets (SBPs) of B1 metallo‐β‐lactamases (MBLs) were compared. Structural compatibility between β‐lactams and MBL SBPs correlates with enzymatic activity, providing insights into the substrate spectrum of MBLs and β‐lactam resistance.
Kiwoong Kwak   +8 more
wiley   +1 more source

Metal nanostructure‐coupled label‐free localized surface plasmon resonance biosensors for rapid and sensitive disease diagnosis

open access: yesBMEMat, EarlyView.
LSPR biosensing enables rapid, sensitive, and low‐sample‐volume detection of biomarkers, with broad applications in diagnosing cancer, infectious, and chronic diseases. Advances in nanostructure design, micro/nanofabrication, and microfluidic integration have expanded the potential of LSPR sensors in biomedical diagnostics.
Zhaoxin Geng   +4 more
wiley   +1 more source

Genomic features of P. aeruginosa PA34.

open access: yes, 2019
Genomic features of P. aeruginosa PA34.
Ajay Kumar Vijay (5802035)   +4 more
core   +1 more source

Compliant hydrogel cuff coating with real‐time pressure monitoring and antibiofilm capabilities for ventilator‐associated pneumonia prophylaxis

open access: yesBMEMat, EarlyView.
A soft‐compliant hydrogel cuff coating combines real‐time pressure monitoring with intrinsic antibacterial activity for prophylaxis of ventilator‐associated pneumonia. A flexible pressure‐sensing patch is embedded in the coating to enable wireless dynamic monitoring of endotracheal cuff pressure through Bluetooth.
Jin Chai   +11 more
wiley   +1 more source

Efficacy and safety of different oral antibacterial therapy regimens for implant-associated infection caused by leading gram-negative pathogens

open access: yesTravmatologiâ i Ortopediâ Rossii
Background. The high level of antibacterial resistance of the leading Gram-negative pathogens causing orthopedic infection complicates the selection of antibacterial drugs at both inpatient and outpatient treatment stages. Research questions.
Olga S. Tufanova   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy